NO995770L - Salter av aromatiske sulfonsyrer - Google Patents

Salter av aromatiske sulfonsyrer

Info

Publication number
NO995770L
NO995770L NO995770A NO995770A NO995770L NO 995770 L NO995770 L NO 995770L NO 995770 A NO995770 A NO 995770A NO 995770 A NO995770 A NO 995770A NO 995770 L NO995770 L NO 995770L
Authority
NO
Norway
Prior art keywords
aromatic sulfonic
salts
sulfonic acids
salt
oxepino
Prior art date
Application number
NO995770A
Other languages
English (en)
Other versions
NO995770D0 (no
Inventor
Gerardus Johannes Heeres
Franciscus Hermanus Anto Bakel
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO995770L publication Critical patent/NO995770L/no
Publication of NO995770D0 publication Critical patent/NO995770D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Oppfinnelsen er et salt av det CNS-depressante trans-5-klor-2,3,3a,12b- tetrahydro-2-metyl-1H-dibenz[2,3:6,7]oksepino[4,5-c]pyrrol og et saltdannende middel, idet sistnevnte er en aromatisk sulfonsyre. Det beskrevne salt, fortrinnsvis benzylatet, har gunstige egenskaper. Således har det den nødvendige uløselig- het og krystallinitet til å være egnet for anvendelse i depot injeksjonspreparater.
NO995770A 1997-05-26 1999-11-25 Salter av aromatiske sulfonsyrer NO995770D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201596 1997-05-26
PCT/EP1998/003022 WO1998054186A1 (en) 1997-05-26 1998-05-19 Salts of aromatic sulphonic acids

Publications (2)

Publication Number Publication Date
NO995770L true NO995770L (no) 1999-11-25
NO995770D0 NO995770D0 (no) 1999-11-25

Family

ID=8228372

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995770A NO995770D0 (no) 1997-05-26 1999-11-25 Salter av aromatiske sulfonsyrer

Country Status (12)

Country Link
EP (1) EP0984968A1 (no)
JP (1) JP2001526702A (no)
KR (1) KR20010012985A (no)
CN (1) CN1257504A (no)
AU (1) AU7767598A (no)
BR (1) BR9809162A (no)
CA (1) CA2290070A1 (no)
HU (1) HUP0002106A3 (no)
NO (1) NO995770D0 (no)
PL (1) PL337027A1 (no)
TR (1) TR199902727T2 (no)
WO (1) WO1998054186A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5067998B2 (ja) 2001-10-30 2012-11-07 ノバルティス アーゲー イロペリドンおよび星形ポリマーのデポー製剤
HRP20020440B1 (en) 2002-05-21 2008-02-29 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
HRP20020452A2 (en) 2002-05-23 2004-02-29 Pliva D D 1,2-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
GB0216416D0 (en) 2002-07-15 2002-08-21 Novartis Ag Organic compounds
EP1802301A1 (en) * 2004-10-15 2007-07-04 Pfizer Inc. Treatment of bipolar disorders and associated symptoms
JP5801295B2 (ja) 2009-06-24 2015-10-28 メルク・シャープ・エンド・ドーム・ベー・フェー アセナピンを含有する注射可能な配合物およびそれを用いた処置方法
ITMI20110734A1 (it) 2011-05-02 2012-11-03 Olon Spa Sali cristallini di asenapina
EP2524919A1 (en) 2011-05-17 2012-11-21 Sandoz AG Novel crystalline salts of Asenapine with organic Di-acids and Tri-acids
EP2524920A1 (en) 2011-05-17 2012-11-21 Sandoz AG Novel Crystalline Asenapine Hydrochloride Salt Forms
EP2524921A1 (en) 2011-05-17 2012-11-21 Sandoz AG Novel Crystalline Salts of Asenapine
AU2017384526B2 (en) 2016-12-20 2023-11-02 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
US11337932B2 (en) 2016-12-20 2022-05-24 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
US11033512B2 (en) 2017-06-26 2021-06-15 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer
CN112704672A (zh) 2018-06-20 2021-04-27 罗曼治疗系统股份公司 含有阿塞那平的透皮治疗系统

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605526A (nl) * 1976-05-24 1977-11-28 Akzo Nv Nieuwe tetracyclische derivaten.

Also Published As

Publication number Publication date
BR9809162A (pt) 2000-08-01
AU7767598A (en) 1998-12-30
HUP0002106A3 (en) 2001-11-28
PL337027A1 (en) 2000-07-31
JP2001526702A (ja) 2001-12-18
CN1257504A (zh) 2000-06-21
TR199902727T2 (xx) 2000-07-21
NO995770D0 (no) 1999-11-25
HUP0002106A2 (hu) 2000-11-28
WO1998054186A1 (en) 1998-12-03
EP0984968A1 (en) 2000-03-15
CA2290070A1 (en) 1998-12-03
KR20010012985A (ko) 2001-02-26

Similar Documents

Publication Publication Date Title
NO995770L (no) Salter av aromatiske sulfonsyrer
CA2268886A1 (en) Aminothiophenecarboxamides
AU3260399A (en) Phenylalanine derivatives as inhibitors of alpha4 integrins
FI973879A0 (fi) Tienyl-,furyl-,pyrrolyl- och bifenylsulfonamider och derivat daerav sommodulerar endotelinativiteten
BG102078A (en) (r)-(z)-1-azabicyclo[2.2.1]heptane-3-on, o-[3-(ethoxyphenyl)-2-propynyl]oxime maleate as a pharmacological formulation
DE69430465T2 (de) Hemmung uteriner Fibrose
AU8154794A (en) Methods of inhibiting seborrhea and acne
AU8156194A (en) Methods of inhibiting dysfunctional uterine bleeding
NO983864L (no) Morfin- og diamorfinsalter av anioniske, ikke-narkotiske analgetika av den substituerte karboksyltypen
EP0800828A4 (en) TRANSMUCOSAL PREPARATION
NO20003784L (no) FremgangsmÕte for fremstilling av enansiomert rene cykloalkanoindolkarboksylsyre og azaindolkarboksylsyrer og pyrimido 1,2a indolkarboksylsyrer og derivater derav
CO4910113A1 (es) Composiciones farmaceuticas estabilizadas, a base de quinu- pristina y de dalfopristina y su preparacion
ATE216237T1 (de) Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade
EP1074264A4 (en) NEOVASCULARIZATION INHIBITORS
NO944920D0 (no) Fremgangsmåte for å inhibere hirsutisme og alopecia hos kvinner
AU3043597A (en) Anticoagulant peptide aldehyde derivatives
AU556243B2 (en) 5-aroyl-4-alkoxy(thioalkyl)pyrrol-2-alkanoic acids
TW343973B (en) Morphinan derivative and medical use
UA43797A (uk) Ін'єкційна форма препарату, що проявляє протиішемічну активність

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application